Antibodies against SARS-CoV-2 control complement-induced inflammatory responses to SARS-CoV-2
M. Bermejo-Jambrina, L. E. H. van der Donk, J. L. van Hamme, D. Wilflingseder, G. de Bree, M. Prins, M. de Jong, P. Nieuwkerk, M. J. van Gils, N. A. Kootstra, T. Geijtenbeek
This study shows that antibodies against SARS-CoV-2 reduce complement-induced inflammation, suggesting a role for complement in immune activation and antibody-mediated immune regulation.
bioRxiv · May 29, 2023 · PreprintImmunology